
Phone No.
(780) 450-3957
This test measures the concentrations of various compounds in products to ensure accurate labeling and compliance with Health Canada's regulations regarding profile and potency.
Key compounds tested include:
• CBD: A non-psychoactive compound with therapeutic potential.
• CBDA: The acidic precursor to CBD.
• CBG: Known as the "parent" compound, from which others are derived.
• CBN: A breakdown product of THC, which may have mild psychoactive effects.
• Other minor compounds: Including CBC, THCV, and more.
This analysis ensures that the product matches the labeled content and adheres to Health Canada guidelines for maximum allowable concentrations in various product forms.